Midodrine Hydrochloride NDC 49884-849

NDC codes

FDA NDC Directory

Product NDC (as listed)49884-849Labeler and product segments. Claims need a package NDC.

Product NDC at billing width49884-0849Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
49884-849-01	49884084901	100 TABLET in 1 BOTTLE (49884-849-01)Marketed from Oct 29, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Midodrine Hydrochloride
Generic name (nonproprietary): midodrine hydrochloride
Active ingredients: Midodrine hydrochloride — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Par Health USA, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207169
Marketing start: Oct 29, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha-Agonists (Mechanism)
Identifiers: Product ID 49884-849_d3af05d0-9d33-4b87-bdfb-a7a2054634cbSPL ID d3af05d0-9d33-4b87-bdfb-a7a2054634cbSPL set ID 863f12bd-d4a9-4547-8667-5dfa9e2ce6d1RxCUI 993462, 993466, 993470UNII 59JV96YTXVUPC 0349884814014, 0349884849016
Pharmacologic class: alpha-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N449884084901 followed by a unit qualifier and the quantity

Package 49884-0849-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 20, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Midodrine hydrochloride tablets, USP are indicated for the treatment of symptomatic orthostatic hypotension (OH). Because midodrine hydrochloride tablets, USP can cause marked elevation of supine blood pressure (BP > 200 mmHg systolic), it should be used in patients whose lives are considerably impaired despite standard clinical care, including non-pharmacologic treatment (such as support stockings), fluid expansion, and lifestyle alterations. The indication is based on midodrine hydrochloride tablets, USP effect on increases in 1-minute standing systolic blood pressure, a surrogate marker considered likely to correspond to a clinical benefit. At present, however, clini…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207169

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207169
Product	Strength	Form · route	Labeler	Product NDC
Midodrine Hydrochloride	Midodrine hydrochloride 2.5 mg/1	TabletOral	Bryant Ranch Prepack	63629-2227
Midodrine Hydrochloride	Midodrine hydrochloride 2.5 mg/1	TabletOral	Par Health USA, LLC	49884-814
Midodrine Hydrochloride	Midodrine hydrochloride 10 mg/1	TabletOral	Par Health USA, LLC	49884-874
Midodrine Hydrochloride	Midodrine hydrochloride 2.5 mg/1	TabletOral	Bryant Ranch Prepack	72162-1517